Intensive intravenous ibandronate treatment significantly relieves opioid-resistant bone pain and improves quality of life in patients with skeletal metastases

被引:1
作者
Body, J. [1 ]
Mancini, I. [1 ]
Dumon, J. [1 ]
机构
[1] Univ Libre Bruxelles, Inst Jules Bordet, Brussels, Belgium
来源
EJC SUPPLEMENTS | 2004年 / 2卷 / 03期
关键词
D O I
10.1016/S1359-6349(04)90868-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
265
引用
收藏
页码:133 / 133
页数:1
相关论文
共 1 条
[1]
Intravenous ibandronate reduces the incidence of skeletal complications in patients with breast cancer and bone metastases [J].
Body, JJ ;
Diel, IJ ;
Lichinitser, MR ;
Kreuser, ED ;
Dornoff, W ;
Gorbunova, VA ;
Budde, M ;
Bergström, B .
ANNALS OF ONCOLOGY, 2003, 14 (09) :1399-1405